Kinetics of preβ1 HDL and αHDL in type II diabetic patients

被引:19
作者
Chétiveaux, M
Lalanne, F
Lambert, G
Zair, Y
Ouguerram, K
Krempf, M
机构
[1] CHU Hotel Dieu, INSERM, U539, Ctr Rech Nutr Humaine, Nantes, France
[2] CHU Hotel Dieu, Clin Endocrinol, Nantes, France
关键词
alpha HDL; apolipoprotein A-I; FPLC; kinetic models; pre beta(1) HDL; type II diabetes;
D O I
10.1111/j.1365-2362.2006.01586.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background The aim of this study was to analyze the recycling of high density lipoprotein (HDL) in six type II diabetic patients compared with six control subjects by endogenous labelling of apolipoprotein A-I (Apo A-I) with stable isotope Apo A. Materials and methods The -I-HDL kinetics were performed by infusion of (5.5.5-H-2(3))-leucine for 14 h. The pre beta(1) and alpha HDL were separated by gel filtration fast protein liquid chromatrography system (FPLC). Kinetics of isotopic enrichment of Apo A-I were analyzed with a multi-compartmental model software (SAAM II, SAAM Institute, Seattle, WA). Results Plasma Apo A-I concentration was decreased in patients with type II diabetes as a result of a decrease in Apo A-I-alpha HDL (P < 0.05). Diabetic patients were also characterized by an increased relative contribution of Apo A-I in pre beta(1) HDL (18.3 +/- 2.8% vs 11.9 +/- 3.7%, P < 0.01). The synthetic rate of pre beta(1) HDL was slightly increased in diabetic patients compared with control (NS) and an increase of recycling rate of alpha to pre beta(1) HDL was observed (11.67 +/- 3.14 d(-1) vs 7.09 +/- 4.51 d(-1), P < 0.05). The clearance rate of Apo A-I was higher in diabetic patients (P < 0.05 for Apo A-I-pre beta(1) HDL and P < 0.005 for Apo A-I-alpha HDL). Conclusion This study suggests that the usual increase in pre beta(1) HDL in type II diabetic patients is mainly related to an increased conversion rate of alpha to pre beta(1) HDL.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 34 条
[1]
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux [J].
Asztalos, BF ;
de la Llera-Moya, M ;
Dallal, GE ;
Horvath, KV ;
Schaefer, EJ ;
Rothblat, GH .
JOURNAL OF LIPID RESEARCH, 2005, 46 (10) :2246-2253
[2]
2-DIMENSIONAL ELECTROPHORESIS OF PLASMA-LIPOPROTEINS - RECOGNITION OF NEW APO-A-I-CONTAINING SUBPOPULATIONS [J].
ASZTALOS, BF ;
SLOOP, CH ;
WONG, L ;
ROHEIM, PS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1169 (03) :291-300
[3]
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients [J].
Brites, FD ;
Cavallero, E ;
de Geitere, C ;
Nicolaïew, N ;
Jacotot, B ;
Rosseneu, M ;
Fruchart, JC ;
Wikinski, RL ;
Castro, GR .
CLINICA CHIMICA ACTA, 1999, 279 (1-2) :1-14
[4]
New model for kinetic studies of HDL metabolism in humans [J].
Chétiveaux, M ;
Ouguerram, K ;
Zair, Y ;
Maugère, P ;
Falconi, I ;
Nazih, H ;
Krempf, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (04) :262-267
[5]
The differential apoA-I enrichment of preβ1 and αHDL is detectable by gel filtration separation [J].
Chétiveaux, M ;
Nazih, H ;
Ferchaud-Roucher, V ;
Lambert, G ;
Zaïr, Y ;
Masson, M ;
Ouguerram, K ;
Bouhours, D ;
Krempf, M .
JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1986-1993
[6]
Collet X, 1999, J LIPID RES, V40, P1185
[7]
Dagher F J, 1965, Adv Surg, V1, P69
[8]
Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus [J].
Duvillard, L ;
Pont, F ;
Florentin, E ;
Gambert, P ;
Vergès, B .
ATHEROSCLEROSIS, 2000, 152 (01) :229-237
[9]
High density lipoprotein apolipoprotein Al kinetics in NIDDM: A stable isotope study [J].
Frenais, R ;
Ouguerram, K ;
Maugeais, C ;
Mahot, P ;
Maugere, P ;
Krempf, M ;
Magot, T .
DIABETOLOGIA, 1997, 40 (05) :578-583
[10]
HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714